Amwell announced positive results from a large study on its SilverCloud digital mental health solution for students.
Quiver AI Summary
Amwell, a leading provider of healthcare technology solutions, announced the results of a significant study of its digital behavioral health platform, SilverCloud®, which was funded by the National Institute of Mental Health and published in Nature Human Behaviour. This randomized trial involved over 6,200 students across 26 U.S. colleges at high risk of mental health issues and demonstrated that proactive digital intervention increased engagement, with 74.4% of participants using SilverCloud compared to only 30.2% using traditional methods. The study found a marked reduction in the prevalence of mental disorders among those using the digital platform, suggesting potential economic benefits, including an estimated $1.18 million saved in future mental health-related costs within the study population. The findings support the integration of digital mental health solutions into broader care strategies for educational institutions and health organizations, highlighting their effectiveness in addressing unmet mental health needs.
Potential Positives
- The results from a significant, large-scale independent study validate SilverCloud® by Amwell®, demonstrating its effectiveness in improving mental health outcomes for students.
- The study shows that participants using SilverCloud engaged at a rate over twice that of traditional behavioral health solutions, indicating higher acceptance and accessibility of digital mental health tools.
- Findings suggest potential economic benefits, with an estimated $1.18 million in avoided mental health–related costs due to the lower prevalence of mental disorders among users of SilverCloud.
- The study supports the strategic role of digital mental health programs in expanding access to care, which may enhance Amwell's position in the healthcare market and attract partnerships with educational institutions and health plans.
Potential Negatives
- The press release focuses on the positive outcomes of SilverCloud but does not address any limitations or potential drawbacks of the program, which could lead to perceptions of bias or lack of transparency.
- While the study shows promising engagement rates, it does not provide specific information on the effectiveness of SilverCloud in real-world scenarios compared to in-person care, leaving a gap in understanding its overall impact on mental health.
- There is no mention of challenges faced during the implementation or acceptance of SilverCloud in diverse student populations, which could raise concerns about the feasibility of broad adoption in different settings.
FAQ
What is the purpose of the study on SilverCloud® by Amwell?
The study aimed to evaluate the effectiveness of digital mental health care for early detection and intervention in students at risk.
How many students participated in the Amwell study?
6,205 students participated, making it one of the largest independent studies of its kind in mental health interventions.
What were the results of using SilverCloud® compared to traditional care?
Participants using SilverCloud had over 74% engagement, significantly higher than the 30% engagement in traditional behavioral health solutions.
What mental health conditions were addressed in the study?
The study focused on anxiety, depression, and eating disorders among students identified as clinically or at high risk.
What potential economic value does the study indicate?
The study suggests that a 3.8% reduction in mental disorders could lead to approximately $1.18 million in avoided mental health-related costs.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$AMWL Insider Trading Activity
$AMWL insiders have traded $AMWL stock on the open market 14 times in the past 6 months. Of those trades, 0 have been purchases and 14 have been sales.
Here’s a breakdown of recent trading of $AMWL stock by insiders over the last 6 months:
- DMITRY ZAMANSKY (Chief Product & Tech. Officer) has made 0 purchases and 3 sales selling 14,290 shares for an estimated $73,298.
- PHYLLIS GOTLIB (President, International) has made 0 purchases and 4 sales selling 14,560 shares for an estimated $70,844.
- MARK HIRSCHHORN (Chief Financial Officer) sold 10,796 shares for an estimated $56,571
- PAUL FRANCIS MCNEICE (Chief Accounting Officer) has made 0 purchases and 4 sales selling 1,010 shares for an estimated $5,031.
- DEBORAH C JACKSON has made 0 purchases and 2 sales selling 612 shares for an estimated $2,883.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$AMWL Revenue
$AMWL had revenues of $54.9M in Q1 2026. This is a decrease of -17.88% from the same period in the prior year.
You can track AMWL financials on Quiver Quantitative's AMWL stock page.
You can access data on AMWL stock through the Quiver Quantitative API.
$AMWL Hedge Fund Activity
We have seen 26 institutional investors add shares of $AMWL stock to their portfolio, and 34 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- SENVEST MANAGEMENT, LLC added 773,834 shares (+213.3%) to their portfolio in Q1 2026, for an estimated $4,070,366
- CALEDONIA (PRIVATE) INVESTMENTS PTY LTD removed 640,000 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $3,142,400
- CABLE CAR CAPITAL, LP added 449,301 shares (+81.2%) to their portfolio in Q1 2026, for an estimated $2,363,323
- JACOBS LEVY EQUITY MANAGEMENT, INC removed 119,849 shares (-100.0%) from their portfolio in Q1 2026, for an estimated $630,405
- SQUAREPOINT OPS LLC removed 97,270 shares (-84.5%) from their portfolio in Q1 2026, for an estimated $511,640
- JANE STREET GROUP, LLC removed 69,003 shares (-56.0%) from their portfolio in Q1 2026, for an estimated $362,955
- GOLDMAN SACHS GROUP INC added 59,487 shares (+92.8%) to their portfolio in Q1 2026, for an estimated $312,901
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$AMWL Price Targets
Multiple analysts have issued price targets for $AMWL recently. We have seen 3 analysts offer price targets for $AMWL in the last 6 months, with a median target of $6.5.
Here are some recent targets:
- Craig Hettenbach from Morgan Stanley set a target price of $6.5 on 05/06/2026
- Charles Rhyee from TD Cowen set a target price of $8.0 on 05/06/2026
- David Grossman from Stifel set a target price of $5.0 on 02/13/2026
Full Release
BOSTON, May 18, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, today highlighted results from an independently led, National Institute of Mental Health-funded randomized trial published in Nature Human Behaviour examining SilverCloud® by Amwell ® , the company’s digital behavioral health solution.
Conducted across 26 U.S. colleges and universities , the study included 6,205 students at clinical or high-risk levels for anxiety, depression, and/or eating disorders , making it one of the largest independent studies of its kind.
The study, led by renowned investigators from Washington University, Penn State University and University of California, Los Angeles, used a proactive care model designed to reach students before conditions worsened. Researchers screened nearly 40,000 students and offered support to those identified as being at elevated risk, rather than relying only on traditional pathways that require students to seek care on their own.
Principal Investigator Michelle G. Newman, PhD, Professor of Psychology and Psychiatry, Penn State University shares her insights on the study:
"Our goal was early detection of those at risk or meeting clinical levels for five mental health conditions, and to test whether digital mental health could move care upstream — reaching people earlier, before symptoms worsen, and doing so at population scale .”
Individuals offered SilverCloud were over twice as likely to engage:
- 74.4% participation with SilverCloud
- 30.2% participation with traditional behavioral health solutions
Compared to screening and referral to in-person care, those who received digital behavioral healthcare had:
- 4.3% lower prevalence of having any mental disorder at six weeks
- 4.9% lower prevalence at six months
-
3.8% lower prevalence at two years
This positive impact was consistent across student populations, including minoritized students and those experiencing financial stress. The findings also point to the potential economic value of prevention and earlier intervention at scale.
When asked about the impact of the study, co-investigator Daniel Eisenberg, PhD, Health Economist, Professor of Health Policy and Management, UCLA said,
“The findings suggest meaningful potential economic value . Taking into account the 3.8% lower prevalence of measured mental disorders at two years, this difference could translate into up to approximately $1.18 million in avoided mental health–related costs within the study sample.”
The findings add to the evidence supporting digital mental health programs as part of a broader care strategy for higher education institutions, health plans, and other organizations seeking to expand access to clinically rigorous support. By combining proactive outreach with a structured digital intervention, the study points to a model that may help address both participation and long-term outcomes in populations with significant unmet need.
About Amwell
Amwell offers payers and health systems a single, comprehensive, technology-enabled care platform. We use technology to provide patients with better access to more convenient, affordable and effective care. The Amwell Platform includes software and services that power many clinical programs from Amwell and our growing number of partners. Our platform allows patients to experience unified, personalized and simple access to diversified clinical programs across the care continuum. As more people seek care online and more clinical programs become available, we offer integrated, future-ready, consistent solutions. The Amwell Platform is proven, operating at a large scale, enabling care for millions of patients and their sponsors while delivering dependable outcomes. For almost two decades, Amwell has proudly served some of the largest and most sophisticated healthcare organizations in the U.S. and worldwide. For more information, visit business.amwell.com or
LinkedIn
.
Investors:
Asher Dewhurst
Media: